| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 57.00B | 55.99B | 57.88B | 56.75B | 69.38B | 64.94B |
| Gross Profit | 15.13B | 14.82B | 16.24B | 13.08B | 13.43B | 11.60B |
| EBITDA | 9.05B | 8.12B | 9.28B | 5.47B | 6.31B | 5.42B |
| Net Income | 3.06B | 3.09B | 4.71B | 252.00M | 2.25B | -3.02B |
Balance Sheet | ||||||
| Total Assets | 100.47B | 100.42B | 92.11B | 86.54B | 82.10B | 80.56B |
| Cash, Cash Equivalents and Short-Term Investments | 2.85B | 4.91B | 3.78B | 6.07B | 5.34B | 3.60B |
| Total Debt | 25.19B | 29.47B | 30.65B | 29.62B | 24.85B | 26.09B |
| Total Liabilities | 64.73B | 65.08B | 59.77B | 57.79B | 53.24B | 53.91B |
| Stockholders Equity | 34.27B | 33.91B | 30.94B | 25.10B | 25.25B | 23.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.32B | -2.32B | -3.70B | 1.90B | -279.00M |
| Operating Cash Flow | 0.00 | 7.17B | 5.70B | 2.09B | 4.09B | 4.21B |
| Investing Cash Flow | 0.00 | -8.56B | -8.50B | -5.59B | -548.00M | -4.38B |
| Financing Cash Flow | 0.00 | 2.38B | 463.00M | 4.14B | -1.87B | 1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥547.04B | 13.65 | 6.55% | 2.71% | -0.06% | 137.47% | |
76 Outperform | ¥76.90B | 12.49 | ― | 6.64% | 2.85% | -9.13% | |
73 Outperform | ¥82.36B | 13.19 | ― | 3.31% | 0.83% | -9.16% | |
72 Outperform | ¥34.83B | 9.33 | ― | 6.14% | -2.08% | -28.12% | |
70 Outperform | ¥159.38B | 7.06 | 10.46% | 2.35% | 4.56% | 49.23% | |
66 Neutral | ¥16.72B | 5.30 | ― | 1.95% | 1.92% | -30.29% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |